Reich Samuel J 4
4 · SAB Biotherapeutics, Inc. · Filed Nov 30, 2023
Insider Transaction Report
Form 4
Reich Samuel J
DirectorCEO
Transactions
- Purchase
Common Stock
2023-11-29$0.89/sh+11,000$9,842→ 219,001 total
Holdings
- 547,698(indirect: By LLC)
Common Stock
Footnotes (2)
- [F1]Represents 11,000 shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), acquired by the reporting person in an open market transaction.
- [F2]Includes 1,000 shares of Common Stock held jointly by the reporting person and the reporting person's spouse.